Kirsi Talala

Association of prostate-specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

Pylväläinen, J., Talala, K., Raitanen, J., Rannikko, A. & Auvinen, A., 22 jan. 2025, I: BJU International. 10 s.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång

Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml: Evidence from the Finnish Randomized Study of Screening for Prostate Cancer

Ola, I. O., Talala, K., Tammela, T., Taari, K., Murtola, T. J., Kujala, P., Raitanen, J. & Auvinen, A., 2024, I: European urology oncology. 8 s.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång

Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)

Talala, K., Walter, S., Taari, K., Tammela, T. L. J., Kujala, P. & Auvinen, A., 2024, I: Cancer Causes & Control. 35, s. 695–703 9 s.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång

Fil

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

Pasanen, N., Talala, K., Remmers, S., Tammela, T. L. J., Hugosson, J., Roobol, M. J., Taari, K., Arnsrud Godtman, R., Bangma, C. & Auvinen, A., 2024, I: BJU International. 134, 2, s. 291-299 9 s.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång

Fil

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

PIONEER Consortium, Siltari, A., Lönnerbro, R., Pang, K., Murtola, T. J., Visakorpi, T., Talala, K., Tammela, T., Turunen, H. & Nevalaita, L., apr. 2023, I: Clinical Genitourinary Cancer. 21, 2, s. 316.e1-316.e11 11 s.

Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review

Öppen tillgång

Fil

Kirsi Talala

Internationellt och inhemskt samarbete

Fördjupning

Association of prostate-specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml: Evidence from the Finnish Randomized Study of Screening for Prostate Cancer

Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

Kirsi Talala

Internationellt och inhemskt samarbete

Publikationer

Association of prostate-specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml: Evidence from the Finnish Randomized Study of Screening for Prostate Cancer

Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis